04-Nov-2026 13:55:46
UNICHEMLABGeneral news
UNICHEM LAB Q2 : CONS NET PROFIT TURNAROUND AT 22.22 CR (YOY), DOWN 46.4% (QOQ). MIX (ON 1ST LOOK)
Revenue up 10.6% at 640.22 Cr (YOY), up 1.2% (QOQ). Ebitda up 3.1% at 89.83 Cr (YOY), up 5.0% (QOQ); margins 14.0% v 15.1% (YOY), 13.5% (QOQ). Caution: Q2 includes ₹24.26 Cr exceptional provision for Laboratories Servier Perindopril claim; prior-year Q2 had ₹58.26 Cr exceptional EU fine interest.
Unichem Laboratories Limited
Open attachment